Supreme Court Rejects Generic Challenge to Otsuka’s Abilify Patent

The U.S. Supreme Court on refused to consider a generic-drug maker’s challenge to Otsuka Pharmaceutical’s U.S. patent for the blockbuster antipsychotic drug Abilify (aripiprazole).
Fox Business